128 related articles for article (PubMed ID: 6996910)
1. Immunological stimulation in situ: the acute and chronic inflammatory responses in the induction of tumor immunity.
Hanna MG; Bucana CD; Pollack VA
Contemp Top Immunobiol; 1980; 10():267-96. PubMed ID: 6996910
[No Abstract] [Full Text] [Related]
2. Immunotherapy of guinea pig cancer with BCG.
Zbar B
Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693
[No Abstract] [Full Text] [Related]
3. An experimental model for immunotherapy of cancer.
Zbar B; Ribi E; Rapp HJ
Natl Cancer Inst Monogr; 1973 Dec; 39():3-9. PubMed ID: 4595326
[No Abstract] [Full Text] [Related]
4. Histopathology of Mycobacterium bovis (BCG)-mediated tumor regression.
Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
Natl Cancer Inst Monogr; 1972 Dec; 35():345-58. PubMed ID: 4349152
[No Abstract] [Full Text] [Related]
5. Induction of delayed-type hypersensitivity and antitumor immunity by systemic BCG.
Hawrylko E
Cell Immunol; 1980 Mar; 50(1):136-52. PubMed ID: 6994895
[No Abstract] [Full Text] [Related]
6. Immunological adjuvants in cancer immunotherapy.
Baldwin RW
Dev Biol Stand; 1977 Apr 13-15; 38():3-12. PubMed ID: 344097
[No Abstract] [Full Text] [Related]
7. The significance of macrophages in human and experimental tumors.
Alexander P; Eccles SA; Gauci CL
Ann N Y Acad Sci; 1976; 276():124-33. PubMed ID: 800321
[No Abstract] [Full Text] [Related]
8. Histologic and ultrastructural studies of tumor regression in inbred guinea pigs after intralesional injection of Mycobacterium bovis (BCG).
Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
Natl Cancer Inst Monogr; 1973 Dec; 39():71-85. PubMed ID: 4362524
[No Abstract] [Full Text] [Related]
9. Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. IV. Development of immunity to tumor cells and BCG.
Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
J Natl Cancer Inst; 1973 Dec; 51(6):1897-908. PubMed ID: 4358147
[No Abstract] [Full Text] [Related]
10. Eradication of microscopic lymph nodes metastases after injection of living BCG adjacent to the primary tumor.
Smith HG; Bast RC; Zbar B; Rapp HJ
J Natl Cancer Inst; 1975 Dec; 55(6):1345-52. PubMed ID: 1107574
[TBL] [Abstract][Full Text] [Related]
11. Radiation therapy and immunotherapy: the value of immunotherapy in the control of local and regional cancer.
Cancer; 1976 Apr; 37(4 Suppl):2108-19. PubMed ID: 769945
[No Abstract] [Full Text] [Related]
12. A HISTOLOGICAL STUDY OF LYMPH NODES DURING THE DEVELOPMENT OF DELAYED HYPERSENSITIVITY TO SOLUBLE ANTIGENS.
TURK JL; HEATHER CJ
Int Arch Allergy Appl Immunol; 1965; 27():199-212. PubMed ID: 14315114
[No Abstract] [Full Text] [Related]
13. The balance of host immunocompetence in chemical carcinogenesis and "nonspecific" immunotherapy.
Hanna MG; Szakal AK; Peters LC
Recent Results Cancer Res; 1975; (52):114-36. PubMed ID: 827793
[No Abstract] [Full Text] [Related]
14. Delayed type hypersensitivity and antituberculous immunity.
Averbakh MM; Gergert VY; Kluyev VA; Kolodiazhnaya NS; Litvinsov VI; Moroz AM
Z Immunitatsforsch Exp Klin Immunol; 1974 Aug; 147(3):204-16. PubMed ID: 4283014
[No Abstract] [Full Text] [Related]
15. The cytotoxic effect in delayed-type hypersensitivity on autologous adherent cells (macrophages) of lymph nodes and spleen.
Lyampert IM; Smirnova MN; Bazanova EA
Cell Immunol; 1980 Jul; 52(2):325-33. PubMed ID: 7002320
[No Abstract] [Full Text] [Related]
16. A comparison of in vitro cell-mediated reactivity against syngeneic tumor cells by various lymphoid cell populations from Bacillus Calmette-Guérin-tumor-cured, tumor-sensitized, tumor-bearing, and normal inbred guinea pigs.
Fidler IJ; Kataoka T; Hanna MG
Cancer Res; 1976 Dec; 36(12):4459-66. PubMed ID: 187324
[TBL] [Abstract][Full Text] [Related]
17. Immunotherapy of guinea pigs with dermal and visceral tumor implants: comparison of living and nonliving BCG.
Yarkoni E; Peters L; Rapp HJ; Hanna MG; Hunter JT
Infect Immun; 1979 May; 24(2):565-66. PubMed ID: 378859
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of anti-tumour immunity in guinea-pigs by methanol extraction residue of BCG.
Wainberg MA; Deutsch V; Weiss DW
Br J Cancer; 1976 Nov; 34(5):500-8. PubMed ID: 187207
[TBL] [Abstract][Full Text] [Related]
19. Tumour models for screening immunomodulators: suppression of tumour growth by delayed hypersensitivity reactions.
Pimm MV; Baldwin RW
Behring Inst Mitt; 1984 May; (74):214-8. PubMed ID: 6383324
[TBL] [Abstract][Full Text] [Related]
20. [A review on mechanism of anti-tumor action of BCG (author's transl)].
Tokunaga T
Kekkaku; 1980 Aug; 55(8):351-7. PubMed ID: 6999202
[No Abstract] [Full Text] [Related]
[Next] [New Search]
